• 1
    Haffner SM, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108: 15411545.
  • 2
    Lean MJ, Han TS. Waist worries. Am J Clin Nutr 2002; 76: 699700.
  • 3
    Wahrenberg H, Hertel K, Leijonhufvud BM et al. Use of waist circumference to predict insulin resistance: retrospective study. BMJ 2005; 330: 13631364.
  • 4
    Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson C. Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 2001; 9: 644646.
  • 5
    World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Geneva, 1998. WHO/NCD/NCS 99.2.
  • 6
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 31433421.
  • 7
    Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003; 107: 16261631.
  • 8
    Heitmann BL, Frederiksen P, Lissner L. Hip circumference and cardiovascular morbidity and mortality in men and women. Obes Res 2004; 12: 482487.
  • 9
    Seidell JC, Han TS, Feskens EJ, Lean ME. Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulin-dependent diabetes mellitus. J Intern Med 1997; 242: 401406.
  • 10
    Snijder MB, Dekker JM, Visser M et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 2003; 77: 11921197.
  • 11
    Ruige JB, Mertens IL, Bartholomeeusen E et al. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal. Obesity 2006; 14: 12501256.
  • 12
    Natali A, Toschi E, Camastra S et al. Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. European Group for the Study of Insulin Resistance (EGIR). Diabetologia 2000; 43: 12661272.
  • 13
    Ferrannini E, Natali A, Capaldo B et al. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997; 30: 11441149.
  • 14
    Ferrannini E, Natali A, Bell P et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997; 100: 11661173.
  • 15
    Ferrannini E, Vichi S, Beck-Nielsen H et al. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 1996; 45: 947953.
  • 16
    Baldeweg SE, Golay A, Natali A et al. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest 2000; 30: 4552.
  • 17
    Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998; 16: 895906.
  • 18
    Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002; 45: 12011210.
  • 19
    Votruba SB, Mattison RS, Dumesic DA, Koutsari C, Jensen MD. Meal fatty acid uptake in visceral fat in women. Diabetes 2007; 56: 25892597.
  • 20
    Maassen JA, Romijn JA, Heine RJ. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia 2007; 50: 20362041.
  • 21
    Maassen JA, Hart LM 't, Ouwens DM. Lessons that can be learned from patients with diabetogenic mutations in mitochondrial DNA: implications for common type 2 diabetes. Curr Opin Clin Nutr Metab Care 2007; 10: 693697.
  • 22
    Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 310.
  • 23
    Ferreira AC, Peter AA, Mendez AJ et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 2004; 110: 35993603.
  • 24
    Fagot-Campagna A, Knowler WC, Narayan KM et al. HDL cholesterol subfractions and risk of developing type 2 diabetes among Pima Indians. Diabetes Care 1999; 22: 271274.
  • 25
    Rizzo M, Corrado E, Coppola G et al. Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis 2008; 200: 389395.
  • 26
    Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201229.
  • 27
    Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 2001; 74: 315321.
  • 28
    Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002; 282: E1023E1028.
  • 29
    Buemann B, Sorensen TI, Pedersen O et al. Lower-body fat mass as an independent marker of insulin sensitivity—the role of adiponectin. Int J Obes Relat Metab Disord 2005; 29: 624631.
  • 30
    Snijder MB, Zimmet PZ, Visser M et al. Independent association of hip circumference with metabolic profile in different ethnic groups. Obes Res 2004; 12: 13701374.
  • 31
    Tirosh A, Shai I, Bitzur R et al. Changes in triglyceride levels over tme and risk of type 2 diabetes in young men. Diabetes Care 2008; 31: 20322037.
  • 32
    Koh-Banerjee P, Wang Y, Hu FB et al. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol 2004; 159: 11501159.
  • 33
    Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993; 92: 21912198.